Lundbeck
HLUN-B.CO
#2582
Rank
C$7.71 B
Marketcap
$8.10
Share price
-0.98%
Change (1 day)
28.32%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Cash on Hand

Cash on Hand as of September 2024 : C$1.78 Billion

According to Lundbeck 's latest financial reports the company has C$1.78 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lundbeck - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.98 B47.22%
2022-12-31C$0.66 B51.18%
2021-12-31C$0.44 B-46.53%
2020-12-31C$0.82 B40.22%
2019-12-31C$0.58 B-57.41%
2018-12-31C$1.38 B85.81%
2017-12-31C$0.74 B76.67%
2016-12-31C$0.42 B36.43%
2015-12-31C$0.30 B-55.54%
2014-12-31C$0.69 B-39.78%
2013-12-31C$1.15 B72.25%
2012-12-31C$0.67 B-4.06%
2011-12-31C$0.69 B66.81%
2010-12-31C$0.41 B2.35%
2009-12-31C$0.40 B-53.76%
2008-12-31C$0.88 B155.81%
2007-12-31C$0.34 B42.42%
2006-12-31C$0.24 B187.64%
2005-12-31C$84.44 M-28.72%
2004-12-31C$0.11 B